Journal Club - Recent Additions

September - 2020

Previous Next    

Showing Journal 5 of 7

Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19 - The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial

The Writing Committee for the REMAP-CAP Investigators JAMA, 2020, online Sept 2020


This is an important trial for a number of reasons. Firstly, it reports the effect of hydrocortisone in COVI-19. Secondly, it is the first publication from REMAP-CAP, an adaptive Bayesian platform trial

In July the RECOVERY trial reported


Previous Comments

No Comments yet.